Improve Research Reproducibility A Bio-protocol resource
bpdetail_icon_lock
Preprint

Immune signature, immune infiltration, and nontumor fraction

YW Yue Wang
DY Da Yang

Last updated date: Feb 22, 2021 Views: 828 Forks: 0

original An abbreviated version of this protocol was published in Science Advances in Feb, 2021
LincRNA-immunity landscape analysis identifies EPIC1 as a regulator of tumor immune evasion and immunotherapy resistance
download pdf Download PDF
ask Ask a question
cite How to cite
nfavorite Favorite

Hi,

The attached file includes the 68 immune signature enrichment and immune cell infiltration estimation across TCGA patients. Just let us know if there you have any further question.

 

Cheers,

Yue

Related files

zip ImmuneSignaturesAndImmuneInfiltration.zip download
Copyright: Content may be subjected to copyright.
How to cite：
Readers should cite both the Bio-protocol preprint and the original research article where this protocol was used:
  1. Wang, Y and Yang, D(2021). Immune signature, immune infiltration, and nontumor fraction. Bio-protocol Preprint. bio-protocol.org/prep865.
  2. Guo, W., Wang, Y., Yang, M., Wang, Z., Wang, Y., Chaurasia, S., Wu, Z., Zhang, M., Yadav, G. S., Rathod, S., Concha-Benavente, F., Fernandez, C., Li, S., Xie, W., Ferris, R. L., Kammula, U. S., Lu, B. and Yang, D.(2021). LincRNA-immunity landscape analysis identifies EPIC1 as a regulator of tumor immune evasion and immunotherapy resistance . Science Advances 7(7). DOI: 10.1126/sciadv.abb3555

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

0/150

tip Tips for asking effective questions

+ Description

Write a detailed description. Include all information that will help others answer your question including experimental processes, conditions, and relevant images.

post Post a Question
0 Q&A
This protocol preprint was submitted via the "Request a Protocol" track.